RBC Europe’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$45K Hold
1,327
﹤0.01% 338
2022
Q1
$46K Sell
1,327
-736
-36% -$25.2K ﹤0.01% 360
2021
Q4
$63K Sell
2,063
-6,086
-75% -$198K ﹤0.01% 334
2021
Q3
$267K Sell
8,149
-576
-7% -$18.4K 0.01% 266
2021
Q2
$264K Buy
+8,725
New +$287K 0.01% 275

Other funds holding OGN

RBC Europe's OGN Position: Q2 2022 in Review

RBC Europe held its Organon & Co (OGN) position steady in Q2 2022 at 1,327 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #338.

RBC Europe first reported a position in OGN in Q2 2021 and has held it in 5 quarters since. The position peaked at $267K in Q3 2021. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • RBC Europe held 1,327 shares of Organon & Co worth $45K as of Q2 2022.
  • RBC Europe left its Organon & Co share count unchanged in Q2 2022.
  • Organon & Co made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #338 holding.
  • RBC Europe first reported a position in Organon & Co in Q2 2021 and has held it in 5 quarters since.
  • RBC Europe's Organon & Co position peaked at $267K in Q3 2021.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.